האיחוד האירופי - פורטוגלית - EMA (European Medicines Agency)

bayer pharma ag - regorafenib - neoplasias colorretais - antineoplastic agents, protein kinase inhibitors - stivarga é indicado como monoterapia para o tratamento de pacientes adultos com:câncer colorretal metastático (crc), que foram previamente tratados com, ou que não são considerados candidatos para, terapias disponíveis - estes incluem fluoropyrimidine base de quimioterapia, um anti-vegf terapia e um anti-egfr terapia;ou metastático, irressecável tumores estromais gastrointestinais (gist), que progrediu ou são intolerantes antes do tratamento com imatinib e sutent;carcinoma hepatocelular (chc), que foram previamente tratados com sorafenib.

פורטוגל - פורטוגלית - Ecolab

ecolab deutschland gmbh -

פורטוגל - פורטוגלית - DGAV (Direção Geral de Alimentação e Veterinária)

cuchillería artero, s.a. - creme - caninos; felinos

האיחוד האירופי - פורטוגלית - EMA (European Medicines Agency)

mylan pharmaceuticals limited - gefitinib - carcinoma, pulmão de células não pequenas - antineoplastic agents, protein kinase inhibitors - gefitinib mylan é indicado como monoterapia para o tratamento de pacientes adultos com localmente avançado ou metastático de células não‑pequenas de câncer de pulmão (nsclc) com mutações ativadoras do egfr‑tk.

האיחוד האירופי - פורטוגלית - EMA (European Medicines Agency)

eigerbio europe limited - lonafarnib - progeria; laminopathies - outro aparelho digestivo e metabolismo produtos, - zokinvy is indicated for the treatment of patients 12 months of age and older with a genetically confirmed diagnosis of hutchinson-gilford progeria syndrome or a processing-deficient progeroid laminopathy associated with either a heterozygous lmna mutation with progerin-like protein accumulation or a homozygous or compound heterozygous zmpste24 mutation.

האיחוד האירופי - פורטוגלית - EMA (European Medicines Agency)

daiichi sankyo europe gmbh - quizartinib dihydrochloride - leucemia, mieloide - antineoplastic agents, protein kinase inhibitors - vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (aml) that is flt3-itd positive.

האיחוד האירופי - פורטוגלית - EMA (European Medicines Agency)

zoetis belgium - inactivated mycoplasma hyopneumoniae, strain p-5722-3, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (orf2) protein, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b orf2 protein - imunológicos para suidae - suínos (para engorda) - active immunisation of pigs against porcine circovirus type 2 to reduce viral load in blood and lymphoid tissues, fecal shedding and the lesions in lymphoid tissues associated with pcv2 infection. protection was demonstrated against porcine circovirus types 2a, 2b and 2d. active immunisation of pigs against mycoplasma hyopneumoniae to reduce the lung lesions associated with mycoplasma hyopneumoniae infection.  onset of immunity (both vaccination schedules): 3 weeks after (the last) vaccination.  duration of immunity (both vaccination schedules): 23 weeks after (the last) vaccination.  in addition, vaccination has been shown to reduce body weight gain losses under field conditions.

האיחוד האירופי - פורטוגלית - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a.  - respiratory syncytial virus recombinant glycoprotein f stabilised in the pre-fusion conformation (rsvpref3) produced in chinese hamster ovary (cho) cells by recombinant dna technology - infecções respiratórias do vírus sincitial - vacinas - arexvy is indicated for active immunisation for the prevention of lower respiratory tract disease (lrtd) caused by respiratory syncytial virus in adults 60 years of age and older. o uso desta vacina deve ser de acordo com as recomendações oficiais.

האיחוד האירופי - פורטוגלית - EMA (European Medicines Agency)

janssen-cilag international nv - ibrutinib - lymphoma, mantle-cell; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, protein kinase inhibitors - imbruvica as a single agent is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl). imbruvica as a single agent or in combination with rituximab or obinutuzumab or venetoclax is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. imbruvica as a single agent or in combination with bendamustine and rituximab (br) is indicated for the treatment of adult patients with cll who have received at least one prior therapy. imbruvica as a single agent is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo immunotherapy. imbruvica in combination with rituximab is indicated for the treatment of adult patients with wm.

האיחוד האירופי - פורטוגלית - EMA (European Medicines Agency)

zoetis belgium sa - synthetic peptide analogue of gnrf conjugated to diptheria toxoid - imunológicos para suidae - male pigs (from 8 weeks of age); female pigs (from 14 weeks of age) - male pigs:induction of antibodies against gnrf to produce a temporary immunological suppression of testicular function. for use as an alternative to physical castration for the reduction of boar taint caused by the key boar taint compound androstenone, in entire male pigs following the onset of puberty. outro contribuidor chave para a mancha de javali, skatole, também pode ser reduzido como um efeito indireto. os comportamentos agressivos e sexuais (de montagem) também são reduzidos. female pigs:induction of antibodies against gnrf to produce a temporary immunological suppression of ovarian function (suppression of oestrus) in order to reduce the incidence of unwanted pregnancies in gilts intended for slaughter, and to reduce the associated sexual behaviour (standing oestrus).